Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT04006288
Brief Title: Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease (SWAP-AC)

First Submitted : June 25, 2019
First Submitted that Met QC Criteria : July 1, 2019
First Posted : July 5, 2019

Last Update Submitted that Met QC Criteria : September 9, 2019
Last Update Posted : September 10, 2019